HER2/neu肽诱导BALB/c小鼠产生特异性CTL及其抑瘤作用的研究

目的：探讨来源于ＨＥＲ２／ｎｅｕ原癌蛋白的多肽诱导特异性细胞免疫应答及其在体内的抗癌效应。方法：利用合成的２个具有小鼠Ｈ－２Ｋ＾ｄ分子结合基序的ＨＥＲ２／ｎｅｕ肽作为肿瘤排斥抗原，在体外刺激小鼠淋巴细胞以及皮下免疫小鼠，观察淋巴细胞的增殖能力、ＣＴＬ的杀伤活性以及ＨＥＲ２／ｎｅｕ肽的抑瘤作用。结果：ＨＥＲ２／ｎｅｕ肽在体内和体外对ＢＡＬＢ／ｃ小鼠淋巴细胞的增殖都有显显的促进作用。ＨＥＲ２／ｎｅｕ肽免疫ＢＡＬＢ／ｃ小鼠后，可以从小鼠淋巴细胞中诱导出肽特异性ＣＴＬ，这些ＣＴＬ可以特异地杀伤ＨＥＲ２／ｎｅｕ阳性ＳＰ２／０细胞，而对ＨＥＲ２／ｎｅｕ阴性ＳＰ２／０细胞却无明显的杀伤活性。ＳＰ２／０ＨＥＲ２细胞在ＨＥＲ２／ｎｅｕ肽免疫小鼠体内的生长受到抑制。结论：研究结果表明ＨＥＲ２／ｎｅｕ肽可以起到一定的抑瘤保护作用，提

Induction of Specific CTLs and Their Tumor Suppressing Activity in BALB/c Mice by Peptide HER2/neu Immunization

Objective: To study the cellular immune responses and the anti-tumor effects induced by peptides derived from onco-protein HER2/neu. Methods: Two HER2/neu peptides compatible with H-2Kd binding motif as tumor rejection antigens were synthesized. The ability of inducing peptide-specific CTLs and suppressing the tumor growth in BALB/c mice immunized by HER2/neu peptide was analyzed. Results: HER2/neu peptides could promote the proliferation of BALB/c lymphocytes both in vitro and in vivo. HER2/neu peptide-specific CTLs could be induced from peptide-immu-nized BALB/c mice, which showed specifically killing effects on HER2/neu positive SP2/OHER2 cells but not on HER2/neu negative SP2/O cells. Moreover, the growth of SP2/OHER2 tumor were significantly suppressed in BALB/c mice immunized with HER2/neu peptides. Conclusion: These results suggested that it was feasible to use MHC-I epitopes derived from tumor-specific antigens as vaccines for cancer immunotherapy.